Contact
Please use this form to send email to PR contact of this press release:
Sarcomatrix Demonstrates Commitment to Diversity and Inclusion in Its Mission to Transform Muscle Disease Treatment
TO:
David Craig
Sarcomatrix Therapeutics Corp.
+1 415-246-3311